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[ [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] hospital records. Medication compliance was assessed
Most available data regarding patient compliance with through a structured telephone interview. Statistical Analysis:
anticoagulant, antiplatelet and risk factor treatment is medication as a significant independent predictor of stroke for both). Compliance was highest with anti-hypertensive in hypertensive patients (O.R. 6.07; 95% C.I:1.53
drugs (98% after MI, 78% after stroke), followed by anti-platelet agents (94% after MI, 75% after stroke) and anti-lipid agents (70% after MI, 59% after stroke). Patients reported simply not feeling the need, acquiring fresh medical advice or a perceived lack of benefit, as reasons for not complying with their discharge prescriptions. Conclusions: Although similar drugs are involved, compliance with prescribed regimens is appreciably lower after stroke than after MI. Our findings underscore the need for better patient education regarding secondary prevention after stroke.
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24.07). [22] Stroke and MI are both life-threatening vascular insults of critical organs. Since the two conditions share common features in pathophysiology and risk-factor profile and therefore in secondary prevention strategies, it would be appropriate to compare noncompliance with pharmacological treatment in these two groups; this would enable us to specifically identify patient-related variables that may predict noncompliant behavior. We tested this hypothesis in the present study using a cross-sectional telephone survey of stroke and MI patients. Our primary objective was to determine the frequency of noncompliance in stroke and MI patients, as lagging compliance may represent an important area of educational and motivational intervention. Secondary objectives were to Arif, et al.: Drug compliance after stroke and MI identify predictors of, and patient-reported reasons for, noncompliance in each patient group.
Materials and Methods
Primarily a cross-sectional survey, this study was conducted in two phases: (i) a retrospective medical record chart review; and (ii) a structured telephone interview. Study design was approved by the Ethics Committee at our institution. In the first phase, using ICD-9-CM This may be especially true in cases where regular followup is not obtained and the need to continue medication is not adequately stressed by a physician/caregiver.
Clinical details of the index stroke or MI were abstracted from the hospital record. Details regarding demographic variables, comorbid conditions, medications prescribed at discharge after the index stroke or MI and length of stay were obtained. Patient compliance was categorized as poor (0-25%), low (26-50%), moderate (51-75%) or high (76-100%), based on the percentage of prescribed (International classification of diseases, ninth revision, medication being consumed as directed. clinical modification) codes, hospital records were Potential subjects were then contacted via telephone screened to identify consecutive adult (age > 18 years) and using a structured questionnaire, we assessed drug patients with first-ever stroke or first-ever MI who had compliance, reasons for noncompliance (if any) to been discharged during a two-year period beginning at treatment prescribed after the index stroke or MI, current least six months prior to the date of the search.
level of disability and education attained. The Stroke was defined as a focal neurological deficit of questionnaire had been pilot-tested in ten patients (five sudden onset, with a corresponding intracerebral lesion with MI and five with stroke) and adjusted accordingly. (infarct or hemorrhage) on brain imaging.
[23] MI was To assess education, the highest level of schooling defined as ST-segment elevation on EKG in association obtained by each subject was recorded (primary or with derangement in cardiac enzymes. The inclusion and secondary school, matriculation, bachelors or exclusion criteria for both groups are listed as follows: postgraduation). However, since the number of patients Inclusion criteria for the stroke group:
in each of these subcategories was small, for the purpose All patients with a stroke (as defined earlier) and CT of the analysis, all subjects who had ever gone to school or MRI revealing a corresponding focal intracerebral were counted as "literate" and collectively analyzed as a ischemic or hemorrhagic lesion and predictor of noncompliance. In an attempt to standardize the analysis of noncompliance in these patients, we thought it appropriate to restrict our patient population to just those patients with first-ever stroke or MI. It is possible that the degree of compliance a patient shows with treatment may differ depending on whether the patient has had a similar/related prior illness. In some cases a secondary insult (MI or stroke) may serve to increase compliance while for others, compliance to treatment may become worse as the patient develops feelings of helplessness and starts doubting the use of medication in the face of recurrent vascular events. of noncompliance. Variables tested as potential predictors included demographic variables (age, gender, level of education), comorbid illness (hypertension, diabetes and dyslipidemia) and hospital length of stay.
Results

Study population
During the study period, 603 patients (325 with stroke, 278 with MI) matched our inclusion criteria, of which 573 (95%) were available for telephone interview. Of the 30 patients who could not be interviewed, 27 had stroke (18 expired, six inaccessible by telephone, three refused consent) and three had MI (all inaccessible by telephone). Thus follow-up data was finally collected on 298 patients with stroke and 275 patients with MI. Table 4 ]. In both the stroke and MI groups, the highest compliance was noted for antihypertensives (78% in stroke group, 98% in MI group; P<0.001), followed by antiplatelet agents (75% in stroke group, 94% in MI group; P< 0.001) and lipid-lowering agents (59% in stroke group, 70% in MI group; P<0.001). The lowest rates of compliance were noted for antidiabetics (28% and 22% to 90% of MI patients were consuming at least half of in the stroke and MI groups, respectively) and their prescription, compared with 68% stroke patients. anticoagulants (7% and 5%); differences across the stroke Overall, stroke patients were significantly less compliant and MI groups for these medication types were not than MI patients [P<0.001 across all categories of statistically significant. compliance; Table 2 ].
Defining "adequate" compliance as consumption of > Reasons cited for noncompliance 50% of the prescribed regimen, we found that adequately Patients (or their surrogates) reporting inadequate compliant patients in both groups were more likely to be compliance (consumption of <50% of prescribed regimen) literate and more likely to report regular post-discharge were questioned about the reasons behind discontinuing follow-up, compared with noncompliant patients prescribed medication [ Table 5 ]. Respondents were asked [P<0.001 for both; Table 3 ]. Additionally, patients with to select all applicable reasons from the following multiple dyslipidemia, though not with other co-morbidities, were choice selection: lack of clinical improvement; did not feel more likely to be adequately compliant (P<0.001). As the the need; received new medical advice; found it too number of co-morbid conditions and discharge expensive; found it too inconvenient; could not tolerate medications increased, a trend towards noncompliant side-effects; could not find it in the market; or other. In behavior was noted in both the stroke and MI groups both the stroke and MI groups, respondents reported that though the difference was not statistically significant they "did not feel the need," as the commonest reason for (results not shown).
not complying with both anti-platelet and lipid-lowering therapy. For anticoagulants, the commonest reason for Compliance with types of medication discontinuation was "new medical advice." For antiWe also examined adequate compliance with particular diabetic medication, "no need felt" and "new medical advice" were cited with equal frequency as reasons for patients and develop more effective strategies to tackle the noncompliance. For anti-hypertensive medication, the population burden of stroke. Judging against post-MI drug leading reasons for noncompliance were "no need felt" compliance, we found that post-stroke drug compliance (MI group) and "new medical advice" (stroke group)." falls significantly short across multiple categories. There Multiple logistic regression showed that illiteracy and are several reasons why post-MI compliance is an important the presence of dyslipidemia as a comorbid condition were benchmark in this comparison. Both ischemic stroke and independent predictors of noncompliance with medication myocardial infarction share pathophysiologic similarities; in the stroke group; in the MI group, female gender and they are associated with similar risk factors; and their illiteracy were predictive of noncompliance [ Table 6 ].
recurrence is prevented by similar measures, including the same types of medication. Moreover, MI as a disease concept 
Discussion
Detailed knowledge about long-term compliance with secondary stroke prevention measures is necessary to reduce rates of stroke recurrence, improve the care of stroke carries a significant and serious public image reflecting urgency and the possibility of devastating consequences, including functional impairment and death -an image that stroke equally deserves but appears not to have achieved.
We noted several differences in baseline characteristics between stroke and MI patients. As our data is based on significantly greater proportion of stroke patients were hospitalization records, this may reflect selection or access illiterate as compared to MI patients and illiteracy emerged bias that could disappear in population-based comparisons. as a predictor of noncompliance. Alternately, as stroke and MI are separate pathologic entities, In the stroke group, patients with dyslipidemia were these observations may represent true differences between more likely to be compliant with medication than those distinct disease populations. Additional studies are needed without dyslipidemia. This may be a chance observation to explore this question further.
that will disappear in a larger sample. On the other hand, Variations in social norms or self-perception may be this observation may truly reflect increased awareness responsible for the differences we have observed. Stroke about the importance of medication use in dyslipidemic patients may be more resigned towards their condition, patients, who may have received reinforcement on this accepting their morbidity as an unavoidable part of old issue from their physicians or other care providers. age. This may, in turn, be responsible for infrequent Simply knowing a target lipid figure that can be lowered follow-up visits in the stroke group. On the other hand, through drug use may also account for greater compliance Sappok et al reported higher compliance rates in older and self-awareness. patients, [24] while another survey showed that primary Female gender was also found to be predictive of care is mainly targeted towards patients who have a high noncompliance. In our population, the reasons for this absolute risk of stroke recurrence. [25] may have a socio-cultural basis. Women in Pakistan have Compared to MI patients, there is a higher level of limited access to healthcare and the health of men (as physical handicap in patients after stroke, which has an earning members of the household) is consistently independent effect on the occurrence of post-stroke prioritized. For women, this may mean fewer encounters depression (PSD). A distinct clinical entity, PSD has a with physicians (to enable reinforcement of the need for one-year cumulative incidence approaching 39%.
[26] A regular medication use) and a deteriorating sense of wellstudy by Sugisawa et al [27] showed that among stroke being, regardless of functional disability. This was also patients subjective well-being and compliance correlates inversely with the degree of depression and impairment in activities of daily living and if three years or more have elapsed since the stroke. Stroke is associated with painless onset and treatment delays. Nondominant hemispheric strokes, moreover, are characterized by anosognosia, which may compound the delay in seeking treatment. In contrast, MI patients may be motivated to comply with secondary prevention in order not to relive the pain and discomfort of the index episode. Community awareness may also play a role. Samsa et al showed that only 41% of individuals at increased risk for stroke were actually aware of their higher risk.
[28] This figure is in contrast to results from the REACT study, [29] which revealed that knowledge of chest pain as an important heart attack symptom is high in the general population (89.7%). Additionally, in our study, a reported in a recent study by Chong et al, [30] who found that among those in the highest functional category, women (with stroke) were more likely to report incomplete recovery and greater need for help than men. Among these women, depressed mood was associated with a response of a need for help despite a good functional recovery. Clearly, patient perception of outcomes after an event such as stroke or MI may differ between men and women and the confounding effects of depression may need to be taken into account in future studies and in clinical practice.
In analyzing compliance by type of drug we found that in both disease groups, the highest compliance rates were for antihypertensive therapy. Previously, compliance rates as high as 90.8% have been reported for antihypertensive drugs. [24] This may be attributable to heightened public awareness about hypertension and its consequences; existence of an objective and visible target such as a numerical blood pressure figure may also be a factor. Somewhat lower compliance figures were seen with antiplatelet and antilipid drugs. The commonest explanation cited by patients for discontinuing these medications is that they simply did not feel the need. Compliance with anticoagulants was low, which is at least partly explained by the constraints imposed by regular physician-patient contact and monitoring.
Our results point to an important area where stroke prevention efforts fail to measure up. The lower drug compliance in stroke patients is unlikely to be due to
